LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 57.18 | 84.90 | 843 | 6963 | 0.1211 | 0.4348 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 57.18 | 84.90 | 6904 | 6963 | 0.9915 | 0.9973 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 58.88 | 84.90 | 752 | 7291 | 0.1031 | 0.4043 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 58.88 | 84.90 | 7354 | 7291 | 1.0085 | 1.0026 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 58.88 | 84.90 | 887 | 7291 | 0.1216 | 0.4409 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 58.88 | 84.90 | 7232 | 7291 | 0.9918 | 0.9974 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 60.59 | 84.90 | 756 | 7641 | 0.0989 | 0.4005 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 60.59 | 84.90 | 7696 | 7641 | 1.0071 | 1.0022 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 60.59 | 84.90 | 892 | 7641 | 0.1167 | 0.4366 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 60.59 | 84.90 | 7558 | 7641 | 0.9890 | 0.9966 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 62.29 | 84.90 | 751 | 7934 | 0.0947 | 0.3952 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 62.29 | 84.90 | 7983 | 7934 | 1.0061 | 1.0019 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 62.29 | 84.90 | 802 | 7934 | 0.1011 | 0.4092 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 62.29 | 84.90 | 7854 | 7934 | 0.9899 | 0.9969 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 63.99 | 84.90 | 795 | 8212 | 0.0968 | 0.4037 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 63.99 | 84.90 | 8372 | 8212 | 1.0194 | 1.0058 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 63.99 | 84.90 | 847 | 8212 | 0.1031 | 0.4173 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 63.99 | 84.90 | 8118 | 8212 | 0.9885 | 0.9965 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 65.70 | 84.90 | 785 | 8484 | 0.0925 | 0.3977 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 65.70 | 84.90 | 8650 | 8484 | 1.0195 | 1.0058 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 65.70 | 84.90 | 894 | 8484 | 0.1054 | 0.4253 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 65.70 | 84.90 | 8422 | 8484 | 0.9927 | 0.9978 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 67.41 | 84.90 | 811 | 8766 | 0.0925 | 0.4012 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 67.41 | 84.90 | 8940 | 8766 | 1.0198 | 1.0059 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 67.41 | 84.90 | 895 | 8766 | 0.1021 | 0.4220 | MN20160318_Q02 | N15 |